Results 201 to 210 of about 44,547 (282)

The Insulinotropic Action of Gastric Inhibitory Polypeptide

Canadian Journal of Physiology and Pharmacology, 1975
The effect of highly purified gastric inhibitory polypeptide (GIP) on immunoreactive insulin (IRI) secretion in the conscious fasted dog was investigated. Significant increases in IRI release were observed with intravenous administration of three different doses of GIP. These were accompanied by depression in fasting serum-glucose levels.
R A, Pederson, H E, Schubert, J C, Brown
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Identification and Actions of Gastric Inhibitory Polypeptide

Recent Progress in Hormone Research, 1975
Publisher Summary This chapter gives an overview of the identification and actions of gastric inhibitory polypeptide (GIP). It describes an experiment in which it is concluded that exogenous or endogenous GIP is capable of insulinotropic effects in normal man and can lead to substantial acceleration of the disposal of glucose.
J C, Brown, J R, Dryburgh, S A, Ross, J, Dupré   +3 more
openaire   +3 more sources

Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide

Best Practice and Research in Clinical Endocrinology and Metabolism, 2004
The 42 amino acid polypeptide glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide (GIP) is released from intestinal K-cells in response to nutrient ingestion. Based on animal studies, the peptide was initially assumed to act as an endogenous inhibitor of gastric acid secretion.
Juris J Meier, Michael A Nauck
exaly   +2 more sources

Gastric inhibitory polypeptide does not inhibit gastric emptying in humans

American Journal of Physiology-Endocrinology and Metabolism, 2004
The insulinotropic gut hormone gastric inhibitory polypeptide (GIP) has been demonstrated to inhibit gastric acid secretion and was proposed to possess “enterogastrone” activity. GIP effects on gastric emptying have not yet been studied. Fifteen healthy male volunteers (23.9 ± 3.3 yr, body mass index 23.7 ± 2.3 kg/m2) were studied with the intravenous
Meier, Juris J, Goetze, Oliver, Anstipp, Jens, Hagemann, Dirk, Holst, Jens Juul, Schmidt, Wolfgang E, Gallwitz, Baptist, Nauck, Michael A   +7 more
openaire   +4 more sources

Pharmacological Actions of Glucagon-Like Peptide-1, Gastric Inhibitory Polypeptide, and Glucagon. [PDF]

International Review of Cell and Molecular Biology, 2016
Glucagon family of peptide hormones is a group of structurally related brain-gut peptides that exert their pleiotropic actions through interactions with unique members of class B1 G protein–coupled receptors (GPCRs).
Revathi Sekar, Kailash Singh, A. Arokiaraj, B. Chow   +3 more
semanticscholar   +2 more sources

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

Nature Medicine, 2002
Udgivelsesdato: 2002-JulSecretion of gastric inhibitory polypeptide (GIP), a duodenal hormone, is primarily induced by absorption of ingested fat. Here we describe a novel pathway of obesity promotion via GIP. Wild-type mice fed a high-fat diet exhibited
K. Miyawaki, Yuichiro Yamada, N. Ban, Y. Ihara, K. Tsukiyama, Heying Zhou, S. Fujimoto, A. Oku, K. Tsuda, S. Toyokuni, H. Hiai, W. Mizunoya, T. Fushiki, J. Holst, M. Makino, A. Tashita, Yuka Kobara, Y. Tsubamoto, Takayoshi Jinnouchi, T. Jomori, Y. Seino   +20 more
semanticscholar   +2 more sources